Danaher (NYSE:DHR) Shares Gap Down – Here’s What Happened

Danaher Corporation (NYSE:DHRGet Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $201.11, but opened at $168.84. Danaher shares last traded at $177.57, with a volume of 5,422,637 shares trading hands.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on DHR shares. JPMorgan Chase & Co. reduced their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Piper Sandler started coverage on Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. DZ Bank began coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Wells Fargo & Company decreased their price target on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Finally, Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Get Our Latest Analysis on DHR

Danaher Stock Performance

The stock has a market cap of $126.78 billion, a PE ratio of 31.82, a P/E/G ratio of 2.19 and a beta of 0.79. The company has a fifty day moving average price of $184.49 and a 200 day moving average price of $197.34. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.06% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.77 EPS. Analysts expect that Danaher Corporation will post 8.49 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s payout ratio is presently 30.95%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in DHR. Main Street Group LTD bought a new stake in Danaher in the 1st quarter worth $25,000. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter valued at about $25,000. Elevated Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at about $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the second quarter worth about $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the fourth quarter worth about $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

(Get Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.